TMEM209 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.788800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.432400E-01
Normal-vs-Stage2
2.310400E-01
Normal-vs-Stage3
4.888200E-02
Normal-vs-Stage4
3.222200E-01
Stage1-vs-Stage2
3.937800E-02
Stage1-vs-Stage3
1.622110E-02
Stage1-vs-Stage4
1.536750E-01
Stage2-vs-Stage3
7.965500E-02
Stage2-vs-Stage4
6.298000E-01
Stage3-vs-Stage4
2.945400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.933400E-01
Normal-vs-AfricanAmerican
8.005600E-01
Normal-vs-Asian
1.537840E-01
Caucasian-vs-AfricanAmerican
4.193400E-01
Caucasian-vs-Asian
1.989440E-01
AfricanAmerican-vs-Asian
1.156430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.556000E-01
Normal-vs-Female
4.319600E-01
Male-vs-Female
6.645600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.336000E-01
Normal-vs-Age(41-60Yrs)
6.704400E-01
Normal-vs-Age(61-80Yrs)
2.640600E-01
Normal-vs-Age(81-100Yrs)
2.335200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.680800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.058000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.343400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.942000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.619200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.960200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.141780E-01
Normal-vs-Daily Drinker
2.669600E-01
Normal-vs-Weekly Drinker
2.292200E-01
Normal-vs-Occasional Drinker
6.482400E-01
Normal-vs-Social Drinker
9.769200E-01
Non Drinker-vs-Daily Drinker
4.548000E-01
Non Drinker-vs-Weekly Drinker
7.505000E-01
Non Drinker-vs-Occasional Drinker
8.668000E-02
Non Drinker-vs-Social Drinker
6.953700E-02
Daily Drinker-vs-Weekly Drinker
7.620600E-01
Daily Drinker-vs-Occasional Drinker
3.311600E-01
Daily Drinker-vs-Social Drinker
1.668990E-01
Weekly Drinker-vs-Occasional Drinker
2.760000E-01
Weekly Drinker-vs-Social Drinker
1.354590E-01
Occasional Drinker-vs-Social Drinker
5.177000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.384200E-01
Normal-vs-Grade 2
6.536400E-01
Normal-vs-Grade 3
1.489750E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.901360E-01
Grade 1-vs-Grade 3
5.051800E-01
Grade 1-vs-Grade 4
3.384200E-01
Grade 2-vs-Grade 3
1.764800E-01
Grade 2-vs-Grade 4
6.536400E-01
Grade 3-vs-Grade 4
1.489750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.331800E-01
Normal-vs-NonDiabetic
4.024800E-01
Diabetic-vs-NonDiabetic
3.216600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.037970E-01
Normal-vs-NoPancreatitis
3.921400E-01
Pancreatitis-vs-NoPancreatitis
2.442000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.204000E-01
Normal-vs-N1
2.184600E-01
N0-vs-N1
2.302800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.213000E-01
Normal-vs-TP53-NonMutant
8.552000E-01
TP53-Mutant-vs-TP53-NonMutant
2.707600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
